Mean time concept and component analysis in pharmacokinetics
- PMID: 10584977
Mean time concept and component analysis in pharmacokinetics
Abstract
In 1958, F.H. Dost [1958] defined the mean life-span ("mittlere Lebensdauer") of a total number of N molecules as the arithmetic mean of all times "z(i)" of any one of the N molecules residing in a pharmacokinetic system. This pharmacokinetic characteristic did not attract special interest for several years. Almost simultaneously Yamaoka et al. [1978], Cutler [1978], van Rossum [1978], Benet and Galeazzi [1979], and von Hattingberg and Brockmeier [1979] recommended the mean residence time (MRT) or mean time (MT) as a useful summarizing characteristic for complex pharmacokinetic systems. One of the most useful properties of the statistical analysis (also called "moment analysis" or "statistical moment analysis") of concentration-time data and in vitro dissolution profiles using moments is the additivity of mean times [von Hattingberg and Brockmeier 1978, 1979]. The very simple and compelling logic of additivity can be explained by the following example: considering an oral administration of a readily available dosage form, the distribution of each individual molecule within the body and the elimination from the body must be preceded by absorption of this molecule, which is trivial. However, as a consequence, the total transit time of an individual molecule through this system is the sum of its time up to absorption into the central circulation z(i).abs and the time the molecule spends in any part of the volume the molecule can reach z(i).vss. Therefore, the total mean time of all drug molecules available is the sum of the mean absorption time MT(abs) and the mean time in the steady-state volume of distribution MTvss. It is obvious that we can estimate the two components of the total mean time, i.e. MTabs and MTvss, by an appropriate experimental setting giving the drug once intravenously and determining MTvss and once giving the drug as an oral solution and deducing MTabs = MTtotal - MTvss. Because of this very useful property of the statistical analysis of concentration-time data by moments, this approach has been entitled "component analysis" [von Hattingberg et al. 1984].
Similar articles
-
The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.Fundam Clin Pharmacol. 2005 Jun;19(3):347-54. doi: 10.1111/j.1472-8206.2005.00329.x. Fundam Clin Pharmacol. 2005. PMID: 15910659 Clinical Trial.
-
Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds.Biopharm Drug Dispos. 2008 Nov;29(8):455-68. doi: 10.1002/bdd.632. Biopharm Drug Dispos. 2008. PMID: 18989850
-
Unifying concept of pharmacokinetics derived from drug distribution and elimination in renal failure.Int J Clin Pharmacol Ther. 1995 Oct;33(10):546-9. Int J Clin Pharmacol Ther. 1995. PMID: 8574504
-
Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part I).Clin Pharmacokinet. 1989 Nov;17(5):345-66. doi: 10.2165/00003088-198917050-00004. Clin Pharmacokinet. 1989. PMID: 2684472 Review.
-
Systems dynamics in clinical pharmacokinetics. An introduction.Clin Pharmacokinet. 1989 Jul;17(1):27-44. doi: 10.2165/00003088-198917010-00003. Clin Pharmacokinet. 1989. PMID: 2663303 Review.
Cited by
-
Realizing time-staggered expression of nucleic acid-encoded proteins by co-delivery of messenger RNA and plasmid DNA on a single nanocarrier.Drug Deliv Transl Res. 2024 Dec;14(12):3339-3353. doi: 10.1007/s13346-024-01668-w. Epub 2024 Jul 15. Drug Deliv Transl Res. 2024. PMID: 39009932
-
The mean dissolution time depends on the dose/solubility ratio.Pharm Res. 2003 Mar;20(3):406-8. doi: 10.1023/a:1022652004114. Pharm Res. 2003. PMID: 12669960